Statement of Cash Flows	8 Months Ended
	Dec. 31, 2019 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (102,604)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(126,688)
Deferred tax benefit	(27,275)
Changes in operating assets and liabilities:
Prepaid expenses	(227,125)
Accrued expenses	214,070
Net cash used in operating activities	(269,622)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(172,500,000)
Net cash used in investing activities	(172,500,000)
Cash Flows from Financing Activities:
Proceeds from sale of Units, net of underwriting discounts paid	169,050,000
Proceeds from sale of Private Warrants	5,200,000
Proceeds from promissory note – related party	137,843
Repayment of promissory note – related party	(137,843)
Payment of offering costs	(459,162)
Net cash provided by financing activities	173,790,838
Net Change in Cash	1,021,216
Cash – April 30, 2019 (inception)
Cash – Ending	1,021,216
Non-cash investing and financing activities:
Initial classification of common stock subject to possible redemption	162,752,250
Change in value of common stock subject to possible redemption	(101,520)
Deferred underwriting fee payable	6,037,500
Deferred offering costs paid directly by Sponsor from proceeds from issuance of Class B common stock to Sponsor	$ 25,000